Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs Orchestra BioMed Holdings, Inc. (OBIO)

Autolus Therapeutics PLC Sponsored ADR and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and Orchestra BioMed Holdings, Inc. are of similar size ($337.8M and $335.4M). Orchestra BioMed Holdings, Inc. grew revenue faster over the last twelve months: 986.1% against 193.3%. Orchestra BioMed Holdings, Inc. has the higher net margin (−186.3% vs −238.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Orchestra BioMed Holdings, Inc. leads on 9 and Autolus Therapeutics PLC Sponsored ADR on 7.

Valuation

Metric AUTL OBIO Biotechnology median
P/E n/m n/m 10.60
P/S 2.90 11.34 9.40
P/B 4.55 18.76 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.83 8.99 9.02
Earnings yield (82.81%) (17.85%) (32.88%)
Free cash flow yield (74.52%) (16.31%) (23.13%)

Profitability

Metric AUTL OBIO Biotechnology median
Gross margin 15.66% 99.51% 68.51%
Operating margin (210.78%) (181.36%) 0.00%
Net margin (238.66%) (186.30%) 0.00%
Free cash flow margin (198.26%) (184.83%) 0.00%
Return on equity (133.00%) (607.32%) (51.96%)
Return on assets (46.15%) (75.16%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AUTL OBIO Biotechnology median
Revenue growth (TTM) 193.29% 986.14% 6.76%
EPS growth (last fiscal year) (25.58%) 33.13% 29.88%
Revenue growth, 5-year CAGR 113.11% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AUTL OBIO Biotechnology median
Debt to equity 1.04 1.80 0.00
Current ratio 4.89 8.26 4.97
Net debt to EBITDA 1.16 1.80 1.01

Dividend

Metric AUTL OBIO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AUTL OBIO Biotechnology median
Market cap 335.36m 337.79m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack